Stem Cell Therapy for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a prospective, randomized, double-blinded, active controlled, single site safety and efficacy study in subjects suffering from chronic wrist osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the wrist.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on immunosuppressant therapy, chemotherapy, or have received a corticosteroid injection in the treatment site.
Is stem cell therapy for osteoarthritis safe?
How is adipose-derived stem cell injection different from other treatments for osteoarthritis?
What data supports the effectiveness of this treatment for osteoarthritis?
Research shows that injecting adipose-derived regenerative cells (ADRCs) into the knee can help improve symptoms and repair cartilage in people with osteoarthritis. Studies in both humans and animal models have demonstrated positive outcomes, such as reduced progression of the disease and improved joint function.156910
Who Is on the Research Team?
Robert Vandermark, MD
Principal Investigator
Sanford Health
Are You a Good Fit for This Trial?
Adults aged 18-75 with chronic wrist osteoarthritis confirmed by symptoms and radiographs, who can consent to participate. Excluded are pregnant or breastfeeding individuals, recent tobacco users, those with substance abuse history, certain infections (HIV, Hepatitis B/C), allergies to specific anesthetics or contrast agents, participants in other trials, chemotherapy patients, vulnerable populations unable to consent properly (e.g., mentally disabled), and those with inflammatory arthritis conditions or carpal tunnel syndrome.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single injection of adipose-derived regenerative cells or corticosteroid into the wrist
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3, 6, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Adipose-derived stem cell injection
- Corticosteroid injection
Adipose-derived stem cell injection is already approved in United States, European Union, Canada for the following indications:
- Osteoarthritis of the facet joint
- Chronic lumbar back pain
- Orthopedic conditions such as osteoarthritis, joint arthritis, degenerative vertebral disks
- Orthopedic conditions such as osteoarthritis, joint arthritis, degenerative vertebral disks
Find a Clinic Near You
Who Is Running the Clinical Trial?
InGeneron, Inc.
Lead Sponsor
Sanford Health
Collaborator